Ohio State University Wexner Medical Center

Ohio State Wexner Medical Center develops regenerative medicine breakthrough

Wednesday, August 9, 2017

Researchers at The Ohio State University Wexner Medical Center and Ohio State’s College of Engineering have developed a new technology, Tissue Nanotransfection (TNT), that can generate any cell type of interest for treatment within the patient’s own body. This technology may be used to repair injured tissue or restore function of aging tissue, including organs, blood vessels and nerve cells.

[Read More]

Peter J. Embi named chair-elect of AMIA board of directors

Tuesday, November 29, 2016

Peter J. Embi, M.D., MS, who joins the Regenstrief Institute as president and CEO on December 15, has been selected as the chair-elect of the board of directors of the American Medical Informatics Association, the largest international professional biomedical and health informatics association. The four-year term includes a one-year term as chair-elect, two years as the chair of the association’s 21-person board of directors, and a final year as chair-emeritus. 

[Read More]

OSU joins PCORnet for healthcare delivery

Monday, October 5, 2015

The Patient-Centered Outcomes Research Institute (PCORI) has awarded the Ohio State University (OSU) College of Medicine and other Patient-Centered Network of Learning Health Systems members—including partners across six states and nine academic medical centers, healthcare systems, public health departments and private health plans—a three-year, $8.6 million grant to participate in a large, national collaborative initiative conducting clinical research more quickly and less expensively.

[Read More]

Cancer Treatment Centers of America names Maurie Markman president

Thursday, May 29, 2014

Cancer Treatment Centers of America (CTCA), a national network of five hospitals that specialize in the treatment of patients fighting complex or advanced-stage cancer, has appointed Maurie Markman, M.D., president of the company’s Medicine & Science unit, where he will be responsible for advancing the organization’s overall commitment to clinical excellence, innovation, safety and patient satisfaction. Markman was senior vice president of Clinical Affairs and national director of Medical Oncology at CTCA.

[Read More]

DIA names Barbara Lopez Kunz global chief executive

Thursday, August 1, 2013

DIA, a neutral, global, professional member-driven association of nearly 18,000 professionals involved in the discovery, development and life cycle management of pharmaceuticals, biotechnology, medical devices and related healthcare products, has named Barbara Lopez Kunz global chief executive, to lead the organization beginning in September. Kunz brings worldwide leadership experience to DIA as former president of the global health and life sciences business at Battelle, an international science and technology nonprofit organization that explores emerging areas of science, develops and commercializes technology and manages laboratories.

[Read More]